Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Angina Pectoris Treatment Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Angina Pectoris Treatment Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Angina Pectoris Treatment Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Angina Pectoris Treatment Market Size Growth Rate by Type
    • 1.4.2 Antiplatelet agents
    • 1.4.3 Beta-adrenergic blocking agents
    • 1.4.4 Calcium channel blockers
    • 1.4.5 Short & Long – acting Nitroglycerines
    • 1.4.6 Angiotensin-converting enzyme (ACE) inhibitors
    • 1.4.7 Anti-ischemic agents
  • 1.5 Market by Application
    • 1.5.1 Global Angina Pectoris Treatment Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Clinic
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Angina Pectoris Treatment Market Size, Estimates and Forecasts
    • 2.1.1 Global Angina Pectoris Treatment Revenue 2015-2026
    • 2.1.2 Global Angina Pectoris Treatment Sales 2015-2026
  • 2.2 Global Angina Pectoris Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Angina Pectoris Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Angina Pectoris Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Angina Pectoris Treatment Competitor Landscape by Players

  • 3.1 Angina Pectoris Treatment Sales by Manufacturers
    • 3.1.1 Angina Pectoris Treatment Sales by Manufacturers (2015-2020)
    • 3.1.2 Angina Pectoris Treatment Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Angina Pectoris Treatment Revenue by Manufacturers
    • 3.2.1 Angina Pectoris Treatment Revenue by Manufacturers (2015-2020)
    • 3.2.2 Angina Pectoris Treatment Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Angina Pectoris Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Angina Pectoris Treatment Revenue in 2019
    • 3.2.5 Global Angina Pectoris Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Angina Pectoris Treatment Price by Manufacturers
  • 3.4 Angina Pectoris Treatment Manufacturing Base Distribution, Product Types
    • 3.4.1 Angina Pectoris Treatment Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Angina Pectoris Treatment Product Type
    • 3.4.3 Date of International Manufacturers Enter into Angina Pectoris Treatment Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Angina Pectoris Treatment Market Size by Type (2015-2020)
    • 4.1.1 Global Angina Pectoris Treatment Sales by Type (2015-2020)
    • 4.1.2 Global Angina Pectoris Treatment Revenue by Type (2015-2020)
    • 4.1.3 Angina Pectoris Treatment Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Angina Pectoris Treatment Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Angina Pectoris Treatment Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Angina Pectoris Treatment Revenue Forecast by Type (2021-2026)
    • 4.2.3 Angina Pectoris Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Angina Pectoris Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Angina Pectoris Treatment Market Size by Application (2015-2020)
    • 5.1.1 Global Angina Pectoris Treatment Sales by Application (2015-2020)
    • 5.1.2 Global Angina Pectoris Treatment Revenue by Application (2015-2020)
    • 5.1.3 Angina Pectoris Treatment Price by Application (2015-2020)
  • 5.2 Angina Pectoris Treatment Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Angina Pectoris Treatment Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Angina Pectoris Treatment Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Angina Pectoris Treatment Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Angina Pectoris Treatment by Country
    • 6.1.1 North America Angina Pectoris Treatment Sales by Country
    • 6.1.2 North America Angina Pectoris Treatment Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Angina Pectoris Treatment Market Facts & Figures by Type
  • 6.3 North America Angina Pectoris Treatment Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Angina Pectoris Treatment by Country
    • 7.1.1 Europe Angina Pectoris Treatment Sales by Country
    • 7.1.2 Europe Angina Pectoris Treatment Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Angina Pectoris Treatment Market Facts & Figures by Type
  • 7.3 Europe Angina Pectoris Treatment Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Angina Pectoris Treatment by Region
    • 8.1.1 Asia Pacific Angina Pectoris Treatment Sales by Region
    • 8.1.2 Asia Pacific Angina Pectoris Treatment Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Angina Pectoris Treatment Market Facts & Figures by Type
  • 8.3 Asia Pacific Angina Pectoris Treatment Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Angina Pectoris Treatment by Country
    • 9.1.1 Latin America Angina Pectoris Treatment Sales by Country
    • 9.1.2 Latin America Angina Pectoris Treatment Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Angina Pectoris Treatment Market Facts & Figures by Type
  • 9.3 Central & South America Angina Pectoris Treatment Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Angina Pectoris Treatment by Country
    • 10.1.1 Middle East and Africa Angina Pectoris Treatment Sales by Country
    • 10.1.2 Middle East and Africa Angina Pectoris Treatment Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Angina Pectoris Treatment Market Facts & Figures by Type
  • 10.3 Middle East and Africa Angina Pectoris Treatment Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Abbott Laboratories Inc.
    • 11.1.1 Abbott Laboratories Inc. Corporation Information
    • 11.1.2 Abbott Laboratories Inc. Description and Business Overview
    • 11.1.3 Abbott Laboratories Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abbott Laboratories Inc. Angina Pectoris Treatment Products Offered
    • 11.1.5 Abbott Laboratories Inc. Related Developments
  • 11.2 Astra Zeneca plc
    • 11.2.1 Astra Zeneca plc Corporation Information
    • 11.2.2 Astra Zeneca plc Description and Business Overview
    • 11.2.3 Astra Zeneca plc Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Astra Zeneca plc Angina Pectoris Treatment Products Offered
    • 11.2.5 Astra Zeneca plc Related Developments
  • 11.3 Bayer AG
    • 11.3.1 Bayer AG Corporation Information
    • 11.3.2 Bayer AG Description and Business Overview
    • 11.3.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Bayer AG Angina Pectoris Treatment Products Offered
    • 11.3.5 Bayer AG Related Developments
  • 11.4 Bristol-Myers Squibb Company
    • 11.4.1 Bristol-Myers Squibb Company Corporation Information
    • 11.4.2 Bristol-Myers Squibb Company Description and Business Overview
    • 11.4.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Bristol-Myers Squibb Company Angina Pectoris Treatment Products Offered
    • 11.4.5 Bristol-Myers Squibb Company Related Developments
  • 11.5 F. Hoffmann-La Roche Ltd
    • 11.5.1 F. Hoffmann-La Roche Ltd Corporation Information
    • 11.5.2 F. Hoffmann-La Roche Ltd Description and Business Overview
    • 11.5.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 F. Hoffmann-La Roche Ltd Angina Pectoris Treatment Products Offered
    • 11.5.5 F. Hoffmann-La Roche Ltd Related Developments
  • 11.6 Forest Laboratories Inc
    • 11.6.1 Forest Laboratories Inc Corporation Information
    • 11.6.2 Forest Laboratories Inc Description and Business Overview
    • 11.6.3 Forest Laboratories Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Forest Laboratories Inc Angina Pectoris Treatment Products Offered
    • 11.6.5 Forest Laboratories Inc Related Developments
  • 11.7 Gilead Sciences, Inc
    • 11.7.1 Gilead Sciences, Inc Corporation Information
    • 11.7.2 Gilead Sciences, Inc Description and Business Overview
    • 11.7.3 Gilead Sciences, Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Gilead Sciences, Inc Angina Pectoris Treatment Products Offered
    • 11.7.5 Gilead Sciences, Inc Related Developments
  • 11.8 GlaxoSmithKline plc
    • 11.8.1 GlaxoSmithKline plc Corporation Information
    • 11.8.2 GlaxoSmithKline plc Description and Business Overview
    • 11.8.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 GlaxoSmithKline plc Angina Pectoris Treatment Products Offered
    • 11.8.5 GlaxoSmithKline plc Related Developments
  • 11.9 Novartis AG
    • 11.9.1 Novartis AG Corporation Information
    • 11.9.2 Novartis AG Description and Business Overview
    • 11.9.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Novartis AG Angina Pectoris Treatment Products Offered
    • 11.9.5 Novartis AG Related Developments
  • 11.10 Pfizer Inc.
    • 11.10.1 Pfizer Inc. Corporation Information
    • 11.10.2 Pfizer Inc. Description and Business Overview
    • 11.10.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Pfizer Inc. Angina Pectoris Treatment Products Offered
    • 11.10.5 Pfizer Inc. Related Developments
  • 11.1 Abbott Laboratories Inc.
    • 11.1.1 Abbott Laboratories Inc. Corporation Information
    • 11.1.2 Abbott Laboratories Inc. Description and Business Overview
    • 11.1.3 Abbott Laboratories Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abbott Laboratories Inc. Angina Pectoris Treatment Products Offered
    • 11.1.5 Abbott Laboratories Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Angina Pectoris Treatment Market Estimates and Projections by Region
    • 12.1.1 Global Angina Pectoris Treatment Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Angina Pectoris Treatment Revenue Forecast by Regions 2021-2026
  • 12.2 North America Angina Pectoris Treatment Market Size Forecast (2021-2026)
    • 12.2.1 North America: Angina Pectoris Treatment Sales Forecast (2021-2026)
    • 12.2.2 North America: Angina Pectoris Treatment Revenue Forecast (2021-2026)
    • 12.2.3 North America: Angina Pectoris Treatment Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Angina Pectoris Treatment Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Angina Pectoris Treatment Sales Forecast (2021-2026)
    • 12.3.2 Europe: Angina Pectoris Treatment Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Angina Pectoris Treatment Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Angina Pectoris Treatment Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Angina Pectoris Treatment Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Angina Pectoris Treatment Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Angina Pectoris Treatment Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Angina Pectoris Treatment Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Angina Pectoris Treatment Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Angina Pectoris Treatment Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Angina Pectoris Treatment Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Angina Pectoris Treatment Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Angina Pectoris Treatment Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Angina Pectoris Treatment Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Angina Pectoris Treatment Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Angina Pectoris Treatment Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Angina Pectoris Treatment Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Angina Pectoris Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Angina Pectoris Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Angina Pectoris Treatment market is segmented into
    Antiplatelet agents
    Beta-adrenergic blocking agents
    Calcium channel blockers
    Short & Long – acting Nitroglycerines
    Angiotensin-converting enzyme (ACE) inhibitors
    Anti-ischemic agents

    Segment by Application, the Angina Pectoris Treatment market is segmented into
    Hospitals
    Clinic
    Other

    Regional and Country-level Analysis
    The Angina Pectoris Treatment market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Angina Pectoris Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Angina Pectoris Treatment Market Share Analysis
    Angina Pectoris Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Angina Pectoris Treatment business, the date to enter into the Angina Pectoris Treatment market, Angina Pectoris Treatment product introduction, recent developments, etc.

    The major vendors covered:
    Abbott Laboratories Inc.
    Astra Zeneca plc
    Bayer AG
    Bristol-Myers Squibb Company
    F. Hoffmann-La Roche Ltd
    Forest Laboratories Inc
    Gilead Sciences, Inc
    GlaxoSmithKline plc
    Novartis AG
    Pfizer Inc.
    Sanofi SA

    Buy now